Alvimopan Capsule
Product Images NDC 0254-3012

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Alvimopan (NDC 0254-3012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Alvimopan (Alvimopan Capsules 1)

Alvimopan (Alvimopan Capsules 1)
Chemical structure of alvimopan dihydrate, showing its molecular configuration including aromatic rings, hydroxyl groups, amide bonds, and dihydrate (2H2O) components as depicted in the image.*
FDA Label Image

Figure 1 (Alvimopan Capsules 2)

Figure 1 (Alvimopan Capsules 2)
Kaplan-Meier curve comparing the estimated probability of achieving an endpoint over time in hours after the end of surgery for Alvimopan versus placebo groups. The x-axis represents hours after surgery, while the y-axis shows the estimated probability of achieving the endpoint up to 1.0. Two lines illustrate cumulative outcomes for Alvimopan (dashed) and placebo (solid).*
FDA Label Image

Figure 2 (Alvimopan Capsules 3)

Figure 2 (Alvimopan Capsules 3)
A Kaplan-Meier curve comparing estimated probability of achieving an endpoint over time between Alvimopan and placebo groups. The x-axis shows hours after end of surgery (0 to 264), and the y-axis shows probability from 0.0 to 1.0. The Alvimopan group is represented by a dashed line and the placebo by a solid line, with Alvimopan showing higher probability sooner.*
FDA Label Image

Alvimopan Carton (Alvimopan Capsules 4)

Alvimopan Carton (Alvimopan Capsules 4)
Packaging label for Alvimopan Capsules 12 mg oral capsules by Par Pharmaceutical. The label indicates hospital use only and contains 30 (6 x 5) unit-dose capsules. Distributed by Par Pharmaceutical, Cranbury, NJ, and manufactured by Par Formulations Private Limited in India. The NDC is 0254-3012-55.*
FDA Label Image

Alvimopan Blister (Alvimopan Capsules 5)

Alvimopan Blister (Alvimopan Capsules 5)
Label for Alvimopan 12 mg capsules from Par Pharmaceutical distributed by Par Health USA, LLC. The label states "HOSPITAL USE ONLY" and includes a barcode, NDC 0254-3012-78, manufacturing license number, and manufacturing origin in India. The label instructs to push through from the front.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.